Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Icu Medical (ICUI) Enterprise Value (2016 - 2026)

Icu Medical's Enterprise Value history spans 17 years, with the latest figure at -$308.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value changed 0.2% year-over-year to -$308.0 million, compared with a TTM value of -$308.0 million through Dec 2025, changed 0.2%, and an annual FY2025 reading of -$308.0 million, changed 0.2% over the prior year.
  • Enterprise Value for Q4 2025 was -$308.0 million at Icu Medical, down from -$299.7 million in the prior quarter.
  • The five-year high for Enterprise Value was -$197.7 million in Q2 2023, with the low at -$567.2 million in Q4 2021.
  • Average Enterprise Value over 5 years is -$315.4 million, with a median of -$299.9 million recorded in 2025.
  • Year-over-year, Enterprise Value skyrocketed 62.45% in 2022 and then tumbled 57.04% in 2024.
  • Tracing ICUI's Enterprise Value over 5 years: stood at -$567.2 million in 2021, then skyrocketed by 62.45% to -$213.0 million in 2022, then dropped by 19.58% to -$254.7 million in 2023, then decreased by 21.14% to -$308.6 million in 2024, then increased by 0.2% to -$308.0 million in 2025.
  • Per Business Quant, the three most recent readings for ICUI's Enterprise Value are -$308.0 million (Q4 2025), -$299.7 million (Q3 2025), and -$300.0 million (Q2 2025).